Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Comparison of Guidelines for the Use of Interleukin-17 Inhibitors for Psoriasis in the United States, Britain, and Europe: A Critical Appraisal and Comprehensive Review.
Journal: The Journal of clinical and aesthetic dermatology
Published: November 22, 2021
Translating the 2019 AAD-NPF Guidelines of Care for Psoriasis With Attention to Comorbidities.
Journal: Cutis
Published: October 18, 2021
Identifying Areas for Improvement in Remote Skin Cancer Management: Surveillance, Diagnostics, and Skin of Color.
Journal: Journal of drugs in dermatology : JDD
Published: July 07, 2021
Understanding the Potential Role of Abrocitinib in the Time of SARS-CoV-2.
Journal: Journal of drugs in dermatology : JDD
Published: July 07, 2021
Assessing the Risk of Apremilast Use for Psoriasis During the COVID-19 Pandemic.
Journal: Journal of drugs in dermatology : JDD
Published: May 03, 2021
Dermatologists as social media contributors during the COVID-19 pandemic.
Journal: Cutis
Published: January 19, 2021
The clinical utility of teledermoscopy in the era of telemedicine.
Journal: Dermatologic therapy
Published: December 20, 2020
Comparison of guidelines for the use of Ustekinumab for psoriasis in the United States, Europe, and the United Kingdom: A critical appraisal and comprehensive review.
Journal: Dermatologic therapy
Published: December 17, 2020
Topical Agents Currently in Phase II or Phase III Trials for Atopic Dermatitis.
Journal: Journal of drugs in dermatology : JDD
Published: October 07, 2020
Reply to Letter to the Editor Regarding: "Applying to dermatology residency during the COVID-19 pandemic".
Journal: Journal of the American Academy of Dermatology
Published: September 21, 2020
Last Updated: 09/26/2026